1. Home
  2. MBBC vs GBIO Comparison

MBBC vs GBIO Comparison

Compare MBBC & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

HOLD

Current Price

$12.18

Market Cap

33.5M

Sector

Finance

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.40

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBBC
GBIO
Founded
1902
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
36.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MBBC
GBIO
Price
$12.18
$5.40
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.88
AVG Volume (30 Days)
2.2K
72.1K
Earning Date
02-22-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$7,299,708.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$106.88
N/A
Revenue Growth
7.77
N/A
52 Week Low
$8.74
$3.00
52 Week High
$12.89
$12.40

Technical Indicators

Market Signals
Indicator
MBBC
GBIO
Relative Strength Index (RSI) 59.69 45.94
Support Level $11.93 $5.31
Resistance Level $12.40 $5.77
Average True Range (ATR) 0.29 0.19
MACD -0.01 -0.01
Stochastic Oscillator 77.60 23.08

Price Performance

Historical Comparison
MBBC
GBIO

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: